| Literature DB >> 29732321 |
Yolande T R Proroga1, Federico Capuano1, Rosanna Capparelli2, Stefano Bilei3, Mariano Bernardo4, Maria Pia Cocco5, Rosalba Campagnuolo6, Vincenzo Pasquale7.
Abstract
Non-typhoidal Salmonella enterica infection is a significant public health problem worldwide. The aim of this study was to characterize Salmonella enterica strains isolated from human specimens in central and southern Italy, for epidemiological studies. One hundred and fifty S. enterica strains were serotyped. Isolates were tested for their antimicrobial susceptibility, by disk diffusion method. The molecular characterizations, based on PCR, were carried out for the detection of invA gene and other virulence elements and phage marker genes. Eighteen different Salmonella serotypes were identified. The most common serotypes detected were S. Typhimurium, S. Enteritidis, the monophasic variant of S. Typhimurium (S. 4,[5],12:i:-), and S. Napoli. High resistance rates were recorded for tetracycline (64%), streptomycin (62%), sulphonamide (57%), and ampicillin (56%). The ASSuT R-type, also associated to resistance to other antibiotics, was highly prevalent in S. 4,[5],12:i:- (97%) and S. Typhimurium (55%), while the ACSSuT R-type, also associated to other antibiotics, was observed prevalently in S. Typhimurium (20.4%). The genes of more common detection were invA (100%), sspH2 (86.6%), gtgB (84.6%), g8 (80%), sodC1 (77.3%), gipA (52.6%), sspH1 (52.6%).Entities:
Keywords: R-type ASSuT; Rtype ACSSuT; Salmonella enterica; antibiotic resistance; human isolates; virulotype
Year: 2018 PMID: 29732321 PMCID: PMC5913695 DOI: 10.4081/ijfs.2018.6888
Source DB: PubMed Journal: Ital J Food Saf ISSN: 2239-7132
Antimicrobial susceptibility patterns (ASSuT, ACSSuT, MDR and XDR) in Salmonella enterica strains.
| Serotype | No. (%) | Pan susceptible | MDR | ASSuT | ASSuT+others | ACSSuT | ACSSuT+others |
|---|---|---|---|---|---|---|---|
| Typhimurium | 49 (32.7) | 3 | 42 | 7 | 20 | 1 | 9 |
| Enteritidis | 40 (26.7) | 31 | 2 | 0 | 0 | 0 | 0 |
| 4,[5],12:i:0 | 37 (24.7) | 0 | 37 | 31 | 5 | 0 | 1 |
| Napoli | 7 (4.7) | 3 | 0 | 0 | 0 | 0 | 0 |
| Derby | 2 (1.3) | 1 | 0 | 0 | 0 | 0 | 0 |
| Poona | 2 (1.3) | 1 | 0 | 0 | 0 | 0 | 0 |
| Rissen | 2 (1.3) | 0 | 0 | 0 | 0 | 0 | 0 |
| Agama | 1 (0.7) | 0 | 1 | 0 | 0 | 0 | 0 |
| Blockley | 1 (0.7) | 0 | 1 | 0 | 0 | 0 | 0 |
| Brandenburg | 1 (0.7) | 0 | 1 | 0 | 0 | 0 | 0 |
| Bredeney | 1 (0.7) | 0 | 1 | 0 | 0 | 0 | 1 |
| Edinburgh | 1 (0.7) | 0 | 1 | 0 | 0 | 0 | 0 |
| Hadar | 1 (0.7) | 0 | 1 | 0 | 0 | 0 | 0 |
| Irumu | 1 (0.7) | 0 | 1 | 0 | 1 | 0 | 0 |
| Manhattan | 1 (0.7) | 0 | 1 | 0 | 0 | 0 | 0 |
| Muenster | 1 (0.7) | 0 | 1 | 0 | 0 | 0 | 0 |
| Nyborg | 1 (0.7) | 0 | 0 | 0 | 0 | 0 | 0 |
| Ohio | 1 (0.7) | 0 | 0 | 0 | 0 | 0 | 1 |
Su: Sulphonamide; T: Tetracycline; S: Streptomycin; A: Ampicillin; C: Chloramphenicol; MDR: non-susceptibility to at least one agent in three or more antimicrobial categories.
Antibiotic resistance profiles in 150 Salmonella strains of human origin.
| Prevalence, % | Resistance profiles |
|---|---|
| 26.0 | Pan susceptible |
| 25.3 | A- S- Su- T |
| 10.0 | A- S- Su- T- Na |
| 2.6 | A- C- S- Su- T- Amc |
| 2.6 | T |
| 2.0 | Na |
| 1.3 | S- Su- T- Na- Stx |
| 1.3 | A- S- Su- T- Cf- Na |
| 1.3 | S- Su- T |
| 1.3 | A- S- Su- T- Amc |
| 1.3 | S |
| 0.6 | Cf |
| 0.6 | Amc-K |
| 0.6 | A |
| 0.6 | T- Cip |
| 0.6 | A- C- S- Amc- Cf |
| 0.6 | A- C- S- Cf |
| 0.6 | A- C- S- Su- T |
| 0.6 | A- S- Su- T- Na- K- Stx |
| 0.6 | A- S- Su- T- Na- Stx |
| 0.6 | A- S- T- Amc- Cf- Na |
| 0.6 | A- C- S- Su- T- Cf- Na |
| 0.6 | A- S- Su- T- K |
| 0.6 | A- C- S- Su- T- K- Stx |
| 0.6 | A- C- S- Su- T- Stx |
| 0.6 | A- S- Su- T- Stx |
| 0.6 | A- S- Su- Amc |
| 0.6 | A- C- S- Su- T- Amc- K |
| 0.6 | A- S- Su- T- Ctx- Caz- Na |
| 0.6 | C- S- Su- T |
| 0.6 | C- S- T |
| 0.6 | A- Su- T- Caz |
| 0.6 | A- C- S- Su- T- Amc- Cu K- Stx |
| 0.6 | A- C- S- Amc- Na- Cip- Enr- Cu K |
| 0.6 | A- C- S- Su- T- Cf- K |
| 0.6 | A- S- Su- T- Cf- Enr- K- Stx |
| 0.6 | A- S- Su- T- Amc- Cf- Stx |
| 0.6 | A- C- S- Su- T- Cf- Na- Enr- Stx- Cl |
| 0.6 | S- T- Na |
| 0.6 | S- T- Na- Enr |
| 0.6 | S- T- Cf- Na- K- Cl |
| 0.6 | S- Su |
| 0.6 | T- Cip |
| 0.6 | Su- T |
| 0.6 | C- Na |
| 0.6 | C- T- Na |
| 0.6 | C- T |
| 0.6 | Cu |
A: Ampicillin; Amc: Amoxicillin-clavulanic acid; C: Chloramphenicol; Caz: Ceftazidime; Cip: Ciprofloxacine; Cl: Colistin sulphate; Cn: Gentamicin; Ctx: Cephotaxime; Enr: Enrofloxacin; K: Kanamycin; Kf: Cephalothin; Na: Nalidixic acid; S: Streptomycin; Su: Sulphonamide; Sxt: Trimethoprim-sulphametoxazole; T: Tetracycline.
Detection of virulence gene in Salmonella strains of human origin.
| Salmonella strain | Phage marker | Virulence gene of phage origin | Plasmidic virulence genes | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Serotype | No. | ||||||||||||||||||
| Typhimurium | 49 | 49 | 6 | 17 | 7 | 47 | 41 | 46 | 1 | 4 | 11 | 36 | 46 | 43 | 5 | 4 | 8 | 8 | 13 |
| Enteritidis | 40 | 40 | 2 | 1 | - | 29 | 8 | 37 | - | - | 37 | 2 | 37 | 38 | 2 | 30 | 37 | 38 | 37 |
| 4,[5],12:i:- | 37 | 37 | - | 1 | 1 | 33 | 37 | 36 | - | - | 14 | 28 | 33 | 33 | - | - | - | - | - |
| Napoli | 7 | 7 | 6 | 1 | - | - | 1 | 7 | - | - | 6 | 6 | 7 | - | - | - | - | - | - |
| Derby | 2 | 2 | 1 | 1 | - | 2 | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Poona | 2 | 2 | 1 | 1 | - | 1 | - | - | - | - | 1 | - | 1 | - | - | - | - | - | 1 |
| Rissen | 2 | 2 | - | 2 | - | 2 | - | - | - | - | - | - | 1 | - | - | - | - | - | - |
| Agama | 1 | 1 | 1 | 1 | - | 1 | 1 | - | - | - | - | - | 1 | - | - | - | - | - | - |
| Blockley | 1 | 1 | - | - | - | - | 1 | 1 | - | - | - | 1 | 1 | 1 | - | - | - | - | - |
| Brandenburg | 1 | 1 | - | - | - | 1 | - | - | - | - | - | 1 | - | - | - | - | - | - | - |
| Bredeney | 1 | 1 | - | - | - | 1 | - | - | - | - | - | 1 | 1 | - | - | - | - | - | - |
| Edinburgh | 1 | 1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Hadar | 1 | 1 | - | - | - | 1 | 1 | - | - | - | - | 1 | 1 | - | - | - | - | - | - |
| Irumu | 1 | 1 | 1 | - | - | 1 | - | - | - | - | - | - | - | 1 | - | - | - | - | - |
| Manhattan | 1 | 1 | - | - | - | - | - | - | - | - | - | 1 | - | - | - | - | - | - | - |
| Muenster | 1 | 1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Nyborg | 1 | 1 | - | - | - | - | - | - | - | - | - | 1 | - | - | - | - | - | - | - |
| Ohio | 1 | 1 | - | 1 | - | 1 | - | - | - | - | - | 1 | 1 | - | - | - | - | - | - |
| All serotypes | 150 | 150 | 18 | 26 | 8 | 120 | 90 | 127 | 1 | 4 | 69 | 79 | 130 | 116 | 7 | 34 | 45 | 46 | 51 |